Villanueva v. People
REITERATIONFacts
1. The Antecedents: The case involves allegations of graft and corrupt practices under Section 3(e) of Republic Act No. 3019, the Anti-Graft and Corrupt Practices Act. The core of the dispute centers on the procurement of medicines by the Municipality of Janiuay, Iloilo, in January 2001. The municipality, through its officials, entered into a Memorandum of Agreement with the Department of Health to implement a disaster program, receiving P15,000,000.00 for the purchase of medicines. A public bidding was conducted, which resulted in the award of contracts to AM-Europharma Corporation and Mallix Drug Center, both owned or controlled by Rodrigo Deriquito Villanueva. The prosecution alleged that this award was made despite AM-Europharma's suspended accreditation and that both entities were owned by the same individual, leading to unwarranted benefits and advantages for Villanueva. 2. Procedural History: The matter was investigated by the Office of the Ombudsman-Visayas, which found probable cause to indict municipal officers and Rodrigo Deriquito Villanueva for violating Section 3(e) of RA 3019. The case proceeded to the Sandiganbayan, which, in its Decision dated February 23, 2015, found petitioner Villanueva and his co-accused public officials guilty beyond reasonable doubt. The Sandiganbayan sentenced them to imprisonment and perpetual disqualification from public office, but assessed no civil liability due to the prosecution's failure to present evidence of actual damage to the government. A motion for reconsideration was denied by the Sandiganbayan in its Resolution dated June 8, 2015. 3. The Petition: Petitioner Rodrigo Deriquito Villanueva filed a petition for review on certiorari under Rule 45 of the Rules of Court, assailing the Sandiganbayan's decision and resolution. He raised ten issues, primarily arguing that the Sandiganbayan erred in convicting him for violations not clearly stated in the amended information, in applying a COA circular that is not a penal law, and in disregarding provisions of law that would allow emergency purchases without public bidding. He also contended that the Sandiganbayan erred in piercing the veil of corporate fiction and in finding conspiracy based on circumstantial evidence. The Supreme Court, however, found that the issues raised by the petitioner primarily involved questions of fact, which are beyond its scope in a Rule 45 petition. The Court affirmed the Sandiganbayan's findings, holding that private individuals can be liable under Section 3(e) of RA 3019 when they conspire with public officials, and that piercing the corporate veil is permissible when juridical entities are used to commit illegal acts.
Issue(s)
Whether the Sandiganbayan erred in convicting the accused for violations not stated under the amended information. Whether the Sandiganbayan erred in convicting the accused under COA Circular No. 92-386, which is not a penal law. Whether the Sandiganbayan erred in finding that the Committee on Awards railroaded the procurement when it acted in accordance with emergency procurement, and whether the Sandiganbayan erred in disregarding Section 368 of RA 7160, which allows emergency purchases without public bidding. Whether the Sandiganbayan erred in disregarding the statutory personality of the League of Municipalities of the Province of Iloilo. Whether the Sandiganbayan erred in accepting Phil. Pharmawealth's denial of participation, and whether the Sandiganbayan erred in faulting the public officers for considering AM Europharma as a qualified bidder. Whether the Sandiganbayan erred in insisting on DOH accreditation as a requirement for local government procurements for medicines, and whether the Sandiganbayan erred in piercing the veil of corporate fiction to consider AM-Europharma Corporation and Mallix Drug Center as one bidder. Whether the Sandiganbayan erred in finding conspiracy based on circumstantial evidence capable of exculpatory interpretation.
Ruling
The petition is denied. The Decision dated February 23, 2015, and Resolution dated June 8, 2015, of the Sandiganbayan in Crim. Case No. SB-08-CRM-0381, finding petitioner Rodrigo Deriquito Villanueva guilty of violating Section 3(e) of Republic Act No. 3019, are affirmed.
Ratio Decidendi
On the sufficiency of the Information and the Sandiganbayan's conviction: The Court held that a complaint or information is sufficient if it states the designation of the offense, the acts or omissions constituting the offense, the name of the offended party, the approximate date, and the place of commission. Section 3(e) of RA 3019 requires that the accused be a public officer discharging administrative, judicial, or official functions; that he acted with manifest partiality, evident bad faith, or gross inexcusable negligence; and that his action caused undue injury to any party, including the government, or gave any private party unwarranted benefits, advantage, or preference. The Amended Information sufficiently alleged these elements, specifically detailing the acts of connivance, manifest partiality, and evident bad faith in awarding contracts to the petitioner's companies despite the suspended accreditation of one and the common ownership of both, thereby giving unwarranted benefits. The petitioner's plea and subsequent defense demonstrated his understanding of the charges, estopping him from claiming vagueness. On the applicability of COA Circular No. 92-386: The Court clarified that the citation of COA Circular No. 92-386 was not to penalize the accused under it, but to illustrate how the noncompliance with its provisions, particularly regarding the determination of a "failed bidding," served as evidence of the public officers' manifest partiality and the giving of unwarranted benefits to the petitioner. The circular's provisions on when public bidding is deemed a failure were relevant in establishing the irregularities that characterized the procurement process, which, when coupled with the petitioner's actions, pointed to a violation of Section 3(e) of RA 3019. On the nature of the procurement and emergency purchases: The Court rejected the petitioner's claim that the transactions were emergency purchases exempt from public bidding under Section 368 of the Local Government Code of 1991. The fact that invitations to bid were issued and a bidding process was conducted contradicted the assertion of an emergency situation. An emergency purchase requires exceptional urgency to prevent imminent danger to life or property, and the steps taken by the municipality indicated a planned procurement process, not a response to an unforeseen emergency. On the statutory personality of the League of Municipalities and the role of public officers: The Court found that the public officers acted in their official capacities as municipal officials of Janiuay, Iloilo, in conducting the bidding and awarding the contracts. While the MOA was coursed through the municipality by virtue of a resolution from the League of Municipalities, the procurement process itself was undertaken by the municipal government. The petitioner's argument that the League's statutory personality should have been considered was deemed irrelevant to the charges of graft and corruption against the municipal officials and the petitioner in their roles concerning the procurement process. On Phil. Pharmawealth's participation and Europharma's qualification: The Court noted that Phil. Pharmawealth disowned its participation, and the evidence showed that Europharma's accreditation was suspended at the time of the bidding, making it unqualified. The petitioner's assertion that accreditation was not relevant was dismissed, as he himself admitted that Europharma's accreditation was non-existent at the time of the bidding. The subsequent issuance of accreditation on January 17, 2001, did not cure the defect of its participation in the January 15, 2001 bidding. On the requirement of DOH accreditation and piercing the corporate veil: The Court affirmed that DOH accreditation was a relevant factor in determining the qualification of bidders for medicines. Furthermore, the Court found that the Sandiganbayan correctly pierced the veil of Europharma's corporate fiction. The petitioner, as the owner of both Europharma and Mallix Drug, used these entities as vehicles to circumvent procurement laws, giving himself unwarranted benefits. The Court reiterated that when a corporate veil is used to perpetrate fraud or illegal acts, it can be lifted to treat the entities as an aggregation of individuals. On conspiracy and circumstantial evidence: The Court held that conspiracy need not be proven by direct evidence and can be inferred from the conduct of the accused. The petitioner's participation in the flawed bidding, acceptance of the award, immediate delivery of medicines, and prompt encashment of payments, along with the fact that both winning bidders were owned by him, demonstrated a joint purpose and concerted action with the public officials. The Court found that the petitioner's actions were indicative of his concurrence in the criminal design, thereby giving him unwarranted benefits, advantage, and preference.
Main Doctrine
A private individual can be held liable under Section 3(e) of Republic Act No. 3019 (Anti-Graft and Corrupt Practices Act) when they conspire with public officers in giving unwarranted benefits, advantage, or preference to a private party, even in the absence of proof of actual damage or injury to the government. The veil of corporate fiction may be pierced when the corporation is used as a vehicle to commit illegal acts or perpetrate fraud.